• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD133 分布揭示了神经胶质瘤干细胞通过对称和不对称细胞分裂进行自我更新。

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.

机构信息

Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Cell Death Dis. 2011 Sep 1;2(9):e200. doi: 10.1038/cddis.2011.80.

DOI:10.1038/cddis.2011.80
PMID:21881602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186899/
Abstract

Malignant gliomas contain a population of self-renewing tumorigenic stem-like cells; however, it remains unclear how these glioma stem cells (GSCs) self-renew or generate cellular diversity at the single-cell level. Asymmetric cell division is a proposed mechanism to maintain cancer stem cells, yet the modes of cell division that GSCs utilize remain undetermined. Here, we used single-cell analyses to evaluate the cell division behavior of GSCs. Lineage-tracing analysis revealed that the majority of GSCs were generated through expansive symmetric cell division and not through asymmetric cell division. The majority of differentiated progeny was generated through symmetric pro-commitment divisions under expansion conditions and in the absence of growth factors, occurred mainly through asymmetric cell divisions. Mitotic pair analysis detected asymmetric CD133 segregation and not any other GSC marker in a fraction of mitoses, some of which were associated with Numb asymmetry. Under growth factor withdrawal conditions, the proportion of asymmetric CD133 divisions increased, congruent with the increase in asymmetric cell divisions observed in the lineage-tracing studies. Using single-cell-based observation, we provide definitive evidence that GSCs are capable of different modes of cell division and that the generation of cellular diversity occurs mainly through symmetric cell division, not through asymmetric cell division.

摘要

恶性神经胶质瘤中存在一群自我更新的肿瘤起始干细胞样细胞;然而,这些神经胶质瘤干细胞(GSCs)如何在单细胞水平上自我更新或产生细胞多样性仍不清楚。不对称细胞分裂是维持癌症干细胞的一种提出的机制,但 GSCs 利用的细胞分裂模式仍未确定。在这里,我们使用单细胞分析来评估 GSCs 的细胞分裂行为。谱系追踪分析表明,大多数 GSCs 是通过扩张性对称细胞分裂产生的,而不是通过不对称细胞分裂产生的。大多数分化后代是在扩张条件下和没有生长因子的情况下通过对称的前承诺分裂产生的,主要通过不对称细胞分裂产生。有丝分裂对分析检测到在有丝分裂的一小部分中,不对称的 CD133 分离,而不是任何其他 GSC 标记,其中一些与 Numb 不对称有关。在生长因子撤出条件下,不对称 CD133 分裂的比例增加,与谱系追踪研究中观察到的不对称细胞分裂的增加一致。通过基于单细胞的观察,我们提供了明确的证据,证明 GSCs 能够进行不同的细胞分裂模式,并且细胞多样性的产生主要通过对称细胞分裂,而不是通过不对称细胞分裂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/42b49ea7d319/cddis201180f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/c79a80a0583c/cddis201180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a978bb18e489/cddis201180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a65beb44938f/cddis201180f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/84312d2797b5/cddis201180f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a18967e79e6e/cddis201180f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/33f60aafcc62/cddis201180f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/42b49ea7d319/cddis201180f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/c79a80a0583c/cddis201180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a978bb18e489/cddis201180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a65beb44938f/cddis201180f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/84312d2797b5/cddis201180f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/a18967e79e6e/cddis201180f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/33f60aafcc62/cddis201180f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad1/3186899/42b49ea7d319/cddis201180f7.jpg

相似文献

1
Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.CD133 分布揭示了神经胶质瘤干细胞通过对称和不对称细胞分裂进行自我更新。
Cell Death Dis. 2011 Sep 1;2(9):e200. doi: 10.1038/cddis.2011.80.
2
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.趋化因子 CXCL12 和其受体 CXCR4 通过 PI3K/AKT 信号通路促进胶质瘤干细胞介导的 VEGF 产生和肿瘤血管生成。
J Pathol. 2011 Jul;224(3):344-54. doi: 10.1002/path.2908. Epub 2011 May 27.
3
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.CD133表达与AC133免疫反应性并不等同,且在胶质瘤干细胞样细胞的整个细胞周期中会发生波动。
PLoS One. 2015 Jun 18;10(6):e0130519. doi: 10.1371/journal.pone.0130519. eCollection 2015.
4
Limits of CD133 as a marker of glioma self-renewing cells.CD133作为胶质瘤自我更新细胞标志物的局限性。
Int J Cancer. 2009 Jul 1;125(1):244-8. doi: 10.1002/ijc.24352.
5
[Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].[小鼠移植人胶质瘤中CD133+细胞表型与微环境关系的初步解读]
Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):564-9.
6
Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.NUMB 通过改变表皮生长因子受体和 Skp1-Cullin-F-box 泛素连接酶活性来调节神经胶质瘤干细胞的命运和生长。
Stem Cells. 2012 Jul;30(7):1313-26. doi: 10.1002/stem.1120.
7
A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.一种新的 2-吡喃酮衍生物,5-溴-3-(3-羟基丙炔基)-2H-吡喃-2-酮,可抑制神经胶质瘤干细胞的干性。
Mol Pharmacol. 2012 Sep;82(3):400-7. doi: 10.1124/mol.112.078402. Epub 2012 May 30.
8
Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.增强体外侵袭和体内 CD133+脑肿瘤干细胞的分布模式。
Chin Med J (Engl). 2011 Sep;124(17):2599-604.
9
The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research.神经球测定、CD133 免疫表型分析和侧群分析在神经胶质瘤干细胞研究中的应用及局限性。
Brain Pathol. 2010 Sep;20(5):877-89. doi: 10.1111/j.1750-3639.2010.00379.x. Epub 2010 Feb 5.
10
Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.存在多能性 CD133+ 细胞与神经胶质瘤的恶性程度相关。
Mol Cell Neurosci. 2010 Jan;43(1):51-9. doi: 10.1016/j.mcn.2008.07.022. Epub 2008 Aug 7.

引用本文的文献

1
Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential.羟基酪醇与脑肿瘤:作用机制及治疗潜力
Curr Issues Mol Biol. 2025 Aug 18;47(8):667. doi: 10.3390/cimb47080667.
2
Cytoplasmic connexin43-microtubule interactions promote glioblastoma stem-like cell maintenance and tumorigenicity.细胞质中连接蛋白43与微管的相互作用促进胶质母细胞瘤干细胞样细胞的维持和致瘤性。
Cell Death Dis. 2025 May 16;16(1):388. doi: 10.1038/s41419-025-07514-2.
3
Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance.

本文引用的文献

1
Genetic variegation of clonal architecture and propagating cells in leukaemia.白血病克隆结构和增殖细胞的遗传异质性。
Nature. 2011 Jan 20;469(7330):356-61. doi: 10.1038/nature09650. Epub 2010 Dec 15.
2
Integrin alpha 6 regulates glioblastoma stem cells.整合素α6 调控神经胶质瘤干细胞。
Cell Stem Cell. 2010 May 7;6(5):421-32. doi: 10.1016/j.stem.2010.02.018.
3
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.胶质母细胞瘤中自我更新肿瘤起始细胞类型的层次结构。
肿瘤异质性、免疫逃逸和治疗抗性交汇处的胶质母细胞瘤干细胞
Cells. 2025 Apr 9;14(8):562. doi: 10.3390/cells14080562.
4
Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?突起小体——一类含有prominin-1/CD133的特殊细胞外囊泡?
J Nanobiotechnology. 2025 Jan 29;23(1):61. doi: 10.1186/s12951-025-03102-w.
5
CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas.CD57 定义了一种新型的癌症干细胞,可驱动弥漫性小儿型高级别神经胶质瘤的侵袭。
Br J Cancer. 2024 Jul;131(2):258-270. doi: 10.1038/s41416-024-02724-5. Epub 2024 Jun 4.
6
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.Prominin-1(CD133)在健康和疾病中参与质膜结构和细胞信号通路动态变化的新兴作用。
Cell Mol Biol Lett. 2024 Mar 26;29(1):41. doi: 10.1186/s11658-024-00554-0.
7
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?脑胶质瘤的癌症干细胞假说 2.0:我们现在在哪里,我们要去哪里?
Neuro Oncol. 2024 May 3;26(5):785-795. doi: 10.1093/neuonc/noae011.
8
Nitric Oxide Prevents Glioblastoma Stem Cells' Expansion and Induces Temozolomide Sensitization.一氧化氮可抑制神经胶质瘤干细胞的扩增并诱导替莫唑胺增敏。
Int J Mol Sci. 2023 Jul 10;24(14):11286. doi: 10.3390/ijms241411286.
9
Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis.靶向肿瘤异质性抑制结直肠癌的化疗耐药和转移。
EMBO Rep. 2023 Aug 3;24(8):e56416. doi: 10.15252/embr.202256416. Epub 2023 Jun 20.
10
Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing.神经胶质瘤干细胞:单细胞测序获得的新数据。
Int J Mol Sci. 2022 Nov 17;23(22):14224. doi: 10.3390/ijms232214224.
Cancer Cell. 2010 Apr 13;17(4):362-75. doi: 10.1016/j.ccr.2009.12.049.
4
The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation.CD133 与胆固醇基膜微区、顶膜突重塑、细胞外膜颗粒之间的有趣联系,以及(神经)上皮细胞分化。
FEBS Lett. 2010 May 3;584(9):1659-64. doi: 10.1016/j.febslet.2010.01.050. Epub 2010 Feb 2.
5
Hematopoietic cytokines can instruct lineage choice.造血细胞因子可指导谱系选择。
Science. 2009 Jul 10;325(5937):217-8. doi: 10.1126/science.1171461.
6
Numb regulates post-endocytic trafficking and degradation of Notch1.Numb调节Notch1的内吞后运输和降解。
J Biol Chem. 2009 Sep 25;284(39):26427-38. doi: 10.1074/jbc.M109.014845. Epub 2009 Jun 30.
7
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.在贴壁培养中扩增的胶质瘤干细胞系具有肿瘤特异性表型,适用于化学和遗传筛选。
Cell Stem Cell. 2009 Jun 5;4(6):568-80. doi: 10.1016/j.stem.2009.03.014.
8
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.SSEA-1是人类胶质母细胞瘤中肿瘤起始细胞的富集标志物。
Cell Stem Cell. 2009 May 8;4(5):440-52. doi: 10.1016/j.stem.2009.03.003.
9
Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways.逆转癌症干细胞:对胶质瘤干细胞信号通路的探索
J Biol Chem. 2009 Jun 19;284(25):16705-16709. doi: 10.1074/jbc.R900013200. Epub 2009 Mar 13.
10
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.同步放化疗联合辅助替莫唑胺与单纯放疗对胶质母细胞瘤生存影响的随机III期研究:EORTC-NCIC试验的5年分析
Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9.